Phase 2 Trial Results Suggest Pitolisant is Effective Therapy for Prader-Willi Syndrome
top of page
The Chi❄n Foundation
The mission of the Chion Foundation is to improve the quality of lives of families touched by Prader-Willi Syndrome (PWS) and other rare diseases. We will do this through identifying new drugs, funding research into the safety and efficacy of those drugs, and facilitating patient access to new drugs. We acknowledge that, in some cases, pharmacological solutions may not be sufficient to relieve all disease burden. In those situations, the Chion Foundation will strive to provide housing and financial relief to individuals whose lives are affected by a rare disease.
The Chion Foundation does not provide medical advice, nor is this site intended to be a substitute for professional medical advice, diagnosis, or treatment.
bottom of page